title: Reduction of clinically manifest colorectal cancer by endoscopic screening: empirical evaluation and comparison of screening at various ages.
abstract: Endoscopic screening (sigmoidoscopy, colonoscopy) with removal of precancerous lesions can prevent a large proportion of colorectal cancers (CRCs). However, there is lack of data regarding optimal age, time intervals and numbers of screening examinations. We developed and applied modified techniques of epidemiological analysis to evaluate the impact of various endoscopy-based screening strategies on prevention of clinically manifest CRCs between the ages of 50 and 79 in a population-based case-control study (294 cases, 254 controls) conducted in Saarland, Germany. We found a strong potential for reduction of CRC occurrence even with a single screening endoscopy. The optimal age for a single screening endoscopy appears to be around 55 (estimated potential for prevention of cases between the ages of 55 and 79 in case of 100% compliance: 77% (95% confidence interval (CI) 46-90%)). A single screening endoscopy at age 50 would have a lower impact due to failure to prevent CRC at higher ages. Similarly, screening at ages 60 or older would have a lower impact because it would fail to prevent CRC at lower ages. Repeated offers of screening examinations could provide substantial additional benefit with the levels of compliance to be expected in practice, but they would have to be weighed against the increased risks and costs.
authors.affiliation: Department of Epidemiology, German Centre for Research on Ageing, Bergheimer Str. 20, D-69115 Heidelberg, Germany. brenner@dzfa.uni-heidelberg.de
authors.forename: H
authors.initials: H
authors.lastname: Brenner
authors.forename: V
authors.initials: V
authors.lastname: Arndt
authors.forename: C
authors.initials: C
authors.lastname: Stegmaier
authors.forename: H
authors.initials: H
authors.lastname: Ziegler
authors.forename: T
authors.initials: T
authors.lastname: Stürmer
mesh_terms: D000367:Age Factors; D000368:Aged; D016022:Case-Control Studies; D003113:Colonoscopy / Q000191:economics / Q000706:statistics & numerical data*; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D016021:Epidemiologic Studies; D005260:Female; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000191:economics; D008875:Middle Aged; D010349:Patient Compliance; D012812:Sigmoidoscopy / Q000191:economics / Q000706:statistics & numerical data*